Coronary plaques are at relative low risk, deriving no benefit from an aggressive therapy, others are high risk individuals who may benefit from more intensive risk modification or even revascularisation [5,12]. Timely detection of silent CAD at an early stage of progression?2014 Faustino et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creativ